Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 4289-4298

  Husain, Shahid ^a   Abdul, Yasir ^a   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; MORPHINE; NEOMYCIN; TUMOR NECROSIS FACTOR ALPHA; CASPASE; NARCOTIC ANALGESIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE MICROSCOPY; GLAUCOMA; INTRAOCULAR HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; UPREGULATION; VISUAL STIMULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BROWN NORWAY RAT; CHRONIC DISEASE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; FOLLOW UP; INTRAOCULAR PRESSURE; METABOLISM; OPTIC NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANALGESICS, OPIOID; ANIMALS; BLOTTING, WESTERN; CASPASES; CELL SURVIVAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; INTRAOCULAR PRESSURE; MALE; MORPHINE; OCULAR HYPERTENSION; OPTIC NERVE; RATS; RATS, INBRED BN; RETINAL GANGLION CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047687026     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9467     Document Type: Article

References (45)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Hernandez MR, Pena JD. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol. 1997;115:389-395.
3. Quigley HA. Experimental glaucoma damage mechanism. Arch Ophthalmol. 1983;101:1301-1302.
4. Husain S, Potter DE. The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther. 2008;24:117-140.
5. Minami M, Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res. 1995;23: 121-145.
6. Howells RD, Kilpatrick DL, Bailey LC, Noe M, Udenfriend S. Proenkephalin mRNA in rat heart. Proc Natl Acad Sci U S A. 1986;83:1960-1963.
7. Salemi S, Aeschlimann A, Reisch N, et al. Detection of kappa and delta opioid receptors in skin-outside the nervous system. Biochem Biophys Res Commun. 2005;338:1012-1017.
8. Husain S, Potter DE, Crosson CE. Opioid-receptor-activation protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2009; 50:3853-3859.
9. Chadzinska M, Savelkoul HF, Verburg-van Kemenade BM. Morphine affects the inflammatory response in carp by impairment of leukocyte migration. Dev Comp Immunol. 2009;33:88-96.
10. Ferri S, Speroni E, Candeletti S, et al. Protection by opioids against gastric lesions caused by necrotizing agents. Pharmacology. 1988;36:140-144.
11. Mayfield KP, D'Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther. 1994; 268:683-688.
12. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89:123-137.
13. Husain S, Liou GI, Crosson CE. Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-alpha in the retina. Invest Ophthalmol Vis Sci. 2011;52: 2577-2583.
14. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 1999;10:119-130.
15. Yang X, Luo C, Cai J, et al. Neurodegenerative and inflammatory pathway components linked to TNF-alpha/ TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci. 2011;52:8442-8454.
16. Tezel G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2001;42:1787-1794.
17. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000;32:42-50.
18. Jenkins HG, Ikeda H. Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J Neurol Sci. 1992;108:99-104.
19. Kitaoka Y, Kwong JM, Ross-Cisneros FN, et al. TNF-alphainduced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci. 2006;47:1448-1457.
20. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res. 1996;18:176-184.
21. Cheung ZH, Chan YM, Siu FK, et al. Regulation of caspase activation in axotomized retinal ganglion cells. Mol Cell Neurosci. 2004;25:383-393.
22. Levkovitch-Verbin H, Harizman N, Dardik R, Nisgav Y, Vander S, Melamed S. Regulation of cell death and survival pathways in experimental glaucoma. Exp Eye Res. 2007;85:250-258.
23. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther. 2002;5:780-787.
24. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
25. Husain S, Whitlock NA, Rice DS, Crosson CE. Effects of latanoprost on rodent intraocular pressure. Exp Eye Res. 2006; 83:1453-1458.
26. Porciatti V. The mouse pattern electroretinogram. Doc Ophthalmol. 2007;115:145-153.
27. Zhang X, Cheng M, Chintala SK. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci. 2004;45:2374-2383.
28. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens. 2008;21:1288-1291.
29. Peng PH, Huang HS, Lee YJ, Chen YS, Ma MC. Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. J Neurochem. 2009;108:741-754.
30. Riazi-Esfahani M, Kiumehr S, Asadi-Amoli F, Dehpour AR. Effects of intravitreal morphine administered at different time points after reperfusion in a rabbit model of ischemic retinopathy. Retina. 2009;29:262-268.
31. Chen TY, Goyagi T, Toung TJ, et al. Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats. Stroke. 2004;35:1180-1185.
32. Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94:960-966.
33. Cui J, Chen Q, Yu LC, Zhang Y. Chronic morphine application is protective against cell death in primary human neurons. Neuroreport. 2008;19:1745-1749.
34. Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001;20:531-561.
35. Wanger P, Persson HE. Pattern-reversal electroretinograms in unilateral glaucoma. Invest Ophthalmol Vis Sci. 1983;24:749-753.
36. Maffei L, Fiorentini A, Bisti S, Hollander H. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res. 1985; 59:423-425.
37. Johnson MA, Drum BA, Quigley HA, Sanchez RM, Dunkelberger GR. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Invest Ophthalmol Vis Sci. 1989;30:897-907.
38. Drago F, Aguglia E, Dal Bello A, et al. Ocular instillation of naloxone increases intraocular pressure in morphine-addicted patients: a possible test for detecting misuse of morphine. Experientia. 1985;41:266-267.
39. Dortch-Carnes J, Potter DE. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005;11:195-212.
40. Dortch-Carnes J, Russell KR. Morphine-induced reduction of intraocular pressure and pupil diameter: role of nitric oxide. Pharmacology. 2006;77:17-24.
41. Stagni E, Bucolo C, Motterlini R, Drago F. Morphine-induced ocular hypotension is modulated by nitric oxide and carbon monoxide: role of mu3 receptors. J Ocul Pharmacol Ther. 2010;26:31-35.
42. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33-44.
43. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995;23:85-91.
44. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997;115:1031-1035.
45. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 1995;375:78-81.